Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study

References

• Borchers, A. T., S. M. Naguwa, Y. Shoenfeld, and M. E. Gershwin. 2010. The geoepidemiology of systemic lupus erythematosus. Autoimmun. Rev. 9: A277–A287
   PubMed Web of Science ®Google Scholar
• Pons-Estel, G. J., G. S. Alarcón, L. Scofield, et al. 2010. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin. Arthritis Rheum. 39: 257–268
   PubMed Web of Science ®Google Scholar
• Trager, J., and M. M. Ward. 2001. Mortality and causes of death in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13: 345–351
   PubMed Web of Science ®Google Scholar
• Pontillo, A., M. Girardelli, A. J. Kamada, et al. 2012. Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 45: 271–278
   PubMed Web of Science ®Google Scholar
• van Rossum, E. F., and E. L. van den Akker. 2011. Glucocorticoid resistance. Endocr. Dev. 20: 127–136
   Google Scholar
• Adcock, I. M., Y. Nasuhara, D. A. Stevens, and P. J. Barnes. 1999. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br. J. Pharmacol. 127: 1003–1011
   PubMed Web of Science ®Google Scholar
• Pui, C. H., G. V. Dahl, G. Rivera, et al. 1984. The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk. Res. 8: 579–585
   PubMed Web of Science ®Google Scholar
• Iacobelli, S., P. Marchetti, G. De Rossi, et al. 1987. Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. Oncology. 44: 13–16
   PubMed Web of Science ®Google Scholar
• Encío, I. J., and S. D. Detera-Wadleigh. 1991. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266: 7182–7188
   PubMed Web of Science ®Google Scholar
• Manenschijn, L., E. L. van den Akker, S. W. Lamberts, and E. F. van Rossum. 2009. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann. N. Y. Acad. Sci. 1179: 179--198
   PubMed Web of Science ®Google Scholar
• Gross, K. L., N. Z. Lu, and J. A. Cidlowski. 2009. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol. Cell Endocrinol. 300: 7–16
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau, N., Z. Amoura, J. S. Hulot, et al. 2007. Hydroxychloroquine in systemic lupus erythematosus. Lancet. 369: 1257–1258
   Google Scholar
• Costedoat-Chalumeau, N., G. Leroux, J. C. Piette, and Z. Amoura. 2010. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment? Joint Bone Spine. 77: 4–5
   Google Scholar
• Carmichael, S. J., B. Charles, and S. E. Tett. 2003. Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther. Drug Monit. 25: 671–681
   PubMed Web of Science ®Google Scholar
• Bateman, A., A. Singh, T. Kral, and S. Solomon. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endocr. Rev. 10: 92–112
   PubMed Web of Science ®Google Scholar
• Jiang, T., S. Liu, M. Tan, et al. 2001. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin. Chim. Acta. 313: 113–117
   PubMed Web of Science ®Google Scholar
• Oakley, R. H., M. Sar, and J. A. Cidlowski. 1996. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271: 9550–9559
   PubMed Web of Science ®Google Scholar
• Reichardt, H. M., and G. Schütz. 1998. Glucocorticoid signalling – multiple variations of a common theme. Mol. Cell Endocrinol. 146: 1–6
   PubMed Web of Science ®Google Scholar
• Pujols, L., A. Xaubet, J. Ramírez, et al. 2004. Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax. 59: 687–693
   PubMed Web of Science ®Google Scholar
• Bamberger, C. M., A. M. Bamberger, M. de Castro, and G. P. Chrousos. 1995. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95: 2435–2441
   PubMed Web of Science ®Google Scholar
• Schaaf, M. J., and J. A. Cidlowski. 2003. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol. Cell Biol. 23: 1922–1934
   PubMed Web of Science ®Google Scholar
• Stahn, C., M. Löwenberg, D. W. Hommes, and F. Buttgereit. 2007. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell Endocrinol. 275: 71–78
   PubMed Web of Science ®Google Scholar
• Ehrchen, J., L. Steinmüller, K. Barczyk, et al. 2007. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood. 109: 1265–1274
   PubMed Web of Science ®Google Scholar
• Gehring, U., K. Mugele, and J. Ulrich. 1984. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol. Cell Endocrinol. 36: 107–113
   PubMed Web of Science ®Google Scholar
• Vanderbilt, J. N., R. Miesfeld, B. A. Maler, and K. R. Yamamoto. 1987. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1: 68–74
   PubMedGoogle Scholar
• Federico, M. H., V. R. Martins, D. H. Pozzi, et al. 1986. Glucocorticoid receptors in acute leukemia. Braz. J. Med. Biol. Res. 19: 167–172
   PubMed Web of Science ®Google Scholar
• Sakurai, M., H. Kamiya, K. Kawai, et al. 1986. Predictable risk factors in children with acute lymphoblastic leukemia. Med. Pediatr. Oncol. 14: 140–143
   Google Scholar
• Niu, N., V. Manickam, K. R. Kalari, et al. 2009. Human glucocorticoid receptor alpha gene (NR3C1) pharmacogenomics: gene resequencing and functional genomics. J. Clin. Endocrinol. Metab. 94: 3072–3084
   Google Scholar
• van Rossum, E. F., J. W. Koper, N. A. Huizenga, et al. 2002. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 51: 3128–3134
   PubMed Web of Science ®Google Scholar